(R)-Imeglimin D3 Hydrochloride

(R)-Imeglimin D3 Hydrochloride is a chemical compound that has recently gained attention in the medical field due to its potential as an anti-diabetic agent. This compound is a deuterated form of (R)-Imeglimin, a drug that is currently in the clinical trial phase for the treatment of type 2 diabetes. The addition of deuterium to the molecule enhances its pharmacokinetic properties, making it more effective and longer-lasting in the body. (R)-Imeglimin D3 Hydrochloride works by targeting the mitochondria in cells, which are responsible for producing energy. It helps to regulate glucose metabolism and improve insulin sensitivity, which are both important factors in managing diabetes. Additionally, this compound has been shown to have a protective effect on the pancreas, which is responsible for producing insulin. In terms of chemical information, (R)-Imeglimin D3 Hydrochloride has a molecular formula of C9H11D3ClN5O and a molecular weight of 244.67 g/mol. It is a white to off-white powder that is soluble in water and ethanol. This compound has a melting point of 243-246°C and a purity of at least 98%. Overall, (R)-Imeglimin D3 Hydrochloride shows promise as a potential treatment for type 2 diabetes and further research is needed to determine its efficacy and safety.